Skip to search.
 STI Down0.96%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

7.88 Down 0.17(2.11%) 23 May 04:00 SGT|After Hours : 7.95 Up 0.07 (0.89%) 23 May 06:52 SGT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.6
Mean Recommendation (last week):1.5
Change:0.1

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:12.44
Median Target:13.00
High Target:15.00
Low Target:8.00
No. of Brokers:9

Data provided by Thomson/First Call
Upgrades & Downgrades History
DateResearch FirmActionFromTo
Dec 13, 2012Maxim GroupInitiated Buy
Nov 13, 2012Burrill Institutional ResearchInitiated Mkt Outperform
May 10, 2012Ladenburg ThalmannUpgradeNeutralBuy
Apr 3, 2012Ladenburg ThalmannDowngradeBuyNeutral
May 17, 2011OppenheimerInitiated Outperform
May 6, 2011MLV CapitalInitiated Buy
Mar 16, 2011JMP SecuritiesInitiated Mkt Outperform
Mar 1, 2010Rodman & RenshawInitiated Mkt Outperform
Feb 25, 2010Roth CapitalInitiated Buy
Mar 11, 2008Banc of America SecDowngradeBuyNeutral
Data provided by Briefing.com

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy4444
Buy5444
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.